Advertisement

Topics

Immunomic Therapeutics Senior Vice President of R&D to Participate in Bio+Tech Conference

06:00 EDT 19 Sep 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Sr. VP of R&D will discuss lysosomal targeting technology as applied in cancer immunotherapy Tomorrow, Teri Heiland, Ph.D., Senior Vice President of Research and Development at Immunomic Therapeutics, Inc. will participa...

Other Sources for this Article

Immunomic Therapeutics, Inc.
Sia Anagnostou, 717-327-1822

NEXT ARTICLE

More From BioPortfolio on "Immunomic Therapeutics Senior Vice President of R&D to Participate in Bio+Tech Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...